zepbound lilly news - Search News

food and drug administration, Lilly

Barron's on MSN · 14h

Eli Lilly’s Weight-Loss Drugs Are No Longer in Short Supply. That’s Bad for Hims & Hers.

Blockbuster drugs Zepbound and Mounjaro have come off the FDA's shortage list. Shares of Hims & Hers, which had capitalized on the pinch, are tumbling.

USA Today · 7h

Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit cheaper copycat versions.

The Wall Street Journal on MSN · 4h

Eli Lilly’s Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making custom-made versions.

ConsumerAffairs9h

Mountjaro, Zepbound removed from FDA's shortage list

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

16h

Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...

1d

Mounjaro and Zepbound no longer in shortage

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

Daily Reporter12h

Eli Lilly’s weight-loss drugs no longer in shortage, FDA says

Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...

8h

Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant

The Medicine Foundry, which is expected to create 400 jobs, will be situated in the LEAP Research and Innovation District in ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results